SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD DEC 04
MCX SILVER DEC 04
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD DEC 04
MCX SILVER DEC 04
MCX CRUDEOIL NOV 19
MCX NATURALGAS NOV 24
USD/INR
EUR/INR
GBP/INR
JPY/INR

Sensex jumps over 300 points, Nifty above 11,850

Wall Street slumps on rising virus cases, fading stimulus hopes

Oil falls more than 1% as surging COVID-19 cases stoke demand fears

The Quandary around Dollar hegemony

Healthcare

Ministry of AYUSH asks Patanjali for composition, research data on 'COVID-19 cure' Coronil, not to publicise claims

Updated : June 24, 2020 07:01 AM IST

The Ministry of AYUSH has asked the company to furnish details of the drug’s composition and the research the company has conducted prior to its launch.

Launching its product earlier Tuesday, Patanjali claimed that the medicine can cure COVID-19 within 14 days.

A majority of coronavirus patients recover without medication within 14 days. Drugs and other intrusive medication is administered in extreme cases.

After Baba Ramdev’s Patanjali Ayurved launched its Ayurvedic medicine, Coronil, claiming that it will help in the treatment of coronavirus infection, the Ministry of AYUSH on Tuesday asked the company to furnish details of the drug’s composition and the research the company has conducted prior to its launch.

“Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined,” the Ministry of AYUSH said in a press release.

The ministry has also asked the Uttarakhand government to provide copies of license and approval details granted for the manufacture of Coronil. Patanjali is headquartered in Haridwar, which comes under Uttarakhand’s jurisdiction.

“Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19,” the statement added.

Launching its product earlier Tuesday, Patanjali claimed that the medicine can cure COVID-19 within 14 days. “Facts of the claim and details of the stated scientific study are not known to the Ministry,” the Ministry of AYUSH statement added.

A majority of coronavirus patients recover without medication within 14 days. Drugs and other intrusive medication is administered in extreme cases.

More than 425,000 people have been infected with coronavirus in India and upwards of 14,000 casualties have been recorded in the country. Globally, the infection tally has crossed the nine million mark while the death toll has climbed upwards of 470,000.

No drug or vaccine for the deadly virus has been discovered so far, albeit Gilead Sciences’ medicine, remdesivir, has been found to reduce the amount of time COVID-19 patients spend in hospital.

You May Also Like

Coronavirus News October 27 Highlights: No change in November unlock guidelines; India fatality rate drops to 1.5%

Coronavirus News October 27 Highlights: No change in November unlock guidelines; India fatality rate drops to 1.5%

Closing Bell: Market gains over 1%, Nifty ends above 11,800; Kotak Mahindra Bank settles 12% higher

Closing Bell: Market gains over 1%, Nifty ends above 11,800; Kotak Mahindra Bank settles 12% higher

October GST collections may cross Rs 1 lakh crore mark

October GST collections may cross Rs 1 lakh crore mark

Trending on CNBC-TV18

Live TV

recommended for you